It’s no question that advancements in lung cancer treatment were in the spotlight at ASCO 2020. Are you caught up? Take our quiz and see how you compare with your colleagues!
Ipilimumab/nivolumab given concomitantly with two cycles of chemotherapy demonstrated prolonged overall survival
June 23, 2020